Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[181]

Pribyl, M.; Hubackova, S.; Moudra, A.; Vancurova, M.; Polackova, H.; Stopka, T.; Jonasova, A.; Bokorova, R.; Fuchs, O.; et al.

Aberrantly elevated suprabasin in the bone marrow as a candidate biomarker of advanced disease state in myelodysplastic syndromes

[year of publication 2020, impact factor 6.603 ]

[182]

Hrustincova, A.; Krejcik, Z.; Kundrat, D.; Szikszai, K.; Belickova, M.; Pecherkova, P.; Klema, J.; Vesela, J.; Hruba, M.; Cermak, J.; Hrdinova, T.; Krijt, M.; Valka, J.; Jonasova, A.; Merkerova, M.D.

Circulating small noncoding RNAs have specific expression patterns in plasma and extracellular vesicles in myelodysplastic syndromes and are predictive of patient outcome

[year of publication 2020, impact factor 6.600 ]

[183]

Rector, A.; Lemey, P.; Tachezy, R.; Mostmans, S.; Ghim, S.J.; Van Doorslaer, K.; Roelke, M.; Bush, M.; Montali, R.J.; Joslin, J.; Burk, R.D.; Jenson, A.B.; Sundberg, J.P.; Shapiro, B.; Van Ranst, M.

Ancient papillomavirus-host co-speciation in Felidae

[year of publication 2008, impact factor 6.589]

[184]

Martínez, C.; Canals, C.; Sarina, B.; Alessandrino, E.P.; Karakasis, D.; Pulsoni, A.; Sica, S.; Trněný, M.; et al.

Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation

[year of publication 2013, impact factor 6.578 ]

[185]

Ghielmini, M; Vitolo, U.; Kimby, E.; Trneny, M.; et al.

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

[year of publication 2014, impact factor 6.578 ]

[186]

Dietrich, S.; Boumendil, A.; Finel, H.; Avivi, I.; Volin, L.; Cornelissen, J.; Jarosinska, R.J.; Schmid, C.; Finke, J.; Stevens, W.B.; Schouten, H.C.; Kaufmann, M.; Sebban, C.; Trneny, M.; Kobbe, G.; Fornecker, L.M.; Schetelig, J.; Kanfer, E.; Heinicke, T.; Pfreundschuh, M.; Diez-Martin, J.L.; Bordessoule, D.; Robinson, S.; Dreger, P.

Outcome and prognostic factors in patients with mantle-cell lymphoma relapsing after autologous stem-cell transplantation: a retrospective study of the European Group for Blood and Marrow Transplantation (EBMT)

[year of publication 2015, impact factor 6.578 ]

[187]

Šestáková, Š.; Cerovská, E.; Cyril Šálek, C.; Kundrát, D.; Ježíšková, I.; Folta, A.; Mayer, J.; Ráčil, Z.; Cetkovský, P.; Remešová, H.

A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel

[year of publication 2022, impact factor 6.551 ]

[188]

Mejstrikova, E.; Volejnikova, J.; Fronkova, E.; Zdrahalova, K.; Kalina, T.; Sterba, J.; Jabali, Y.; Mihal, V.; Blazek, B.; Cerna, Z.; Prochazkova, D.; Hak, J.; Zemanova, Z.; Jarosova, M.; Oltova, A.; Sedlacek, P.; Schwarz, J.; Zuna, J.; Trka, J.; Stary, J.; Hrusak, O.

Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria

[year of publication 2010, impact factor 6.532]

[189]

Vojtechova, Z.; Sabol, I.; Salakova, M.; Turek, L.; Grega, M.; Smahelova, J.; Vencalek, O.; Lukesova, E.; Klozar, J.; Tachezy, R.

Analysis of the integration of human papillomaviruses in head and neck tumors in relation to patients' prognosis

[year of publication 2015, impact factor 6.513 ]

[190]

Matousek, J.; Gotte, G.; Pouckova, P.; Soucek, J.; Slavik, T.; Vottariello, F.; Libonati, M.

Antitumor activity and other biological actions of oligomers of ribonuclease A*

[year of publication 2006, impact factor 6.482]

[191]

Durkin, M.E.; Ullmannova, V.; Guan, M.; Popescu, N.C.

Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth

[year of publication 2007, impact factor 6.440]

[192]

Cruciani, F.; La Fratta, R.; Trombetta, B.; Santolamazza, P.; Sellitto, D.; Colomb, E.B.; Dugoujon, J.-M.; Crivellaro, F.; Benincasa, T.; Pascone, R.; Moral, P.; Watson, E.; Melegh, B.; Barbujani, G.; Fuselli, S.; Vona, G.; Zagradisnik, B.; Assum, G.; Brdicka, R.; Kozlov, A.I.; Efremov, G.D.; Coppa, A.; Novelletto, A.; Scozzari, R.

Tracing past human male movements in northern/eastern Africa and western Eurasia : new clues from Y-chromosomal haplogroups E-M78 and J-M12

[year of publication 2007, impact factor 6.438]

[193]

Julian, B.A.; Brantley jr., R.R.; Barker, C.V.; Stopka, T.; Gaston, R.S.; Curtis, J.J.; Lee, J.Y.; Prchal, J.T.

Losartan, an angiotensin II type 1 receptor antigonist, lowers hematocrit in posttransplant erythrocytosis

[year of publication 2006, impact factor 6.361]

[194]

Kaufmanova, J.; Stikarova, J.; Hlavackova, A.; Chrastinova, L.; Maly, M.; Suttnar, J.; Dyr, J.E.

Fibrin clot formation under oxidative stress conditions

[year of publication 2021, impact factor 6.312 ]

[195]

Cmejla, R.; Cmejlova, J.; Handrkova, H.; Petrak, J.; Pospisilova, D.

Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia

[year of publication 2008, impact factor 6.273]

[196]

Curik, N.; Polivkova, V.; Burda, P.; Koblihova, J.; Laznicka, A.; Kalina, T.; Kanderova, V.; Brezinova, J.; Ransdorfova, S.; Karasova, D.; Rejlova, K.; Bakardjieva, M.; Kuzilkova, D.; Kundrat, D.; Linhartova, J.; Klamova, H.; Salek, C.; Klener, P.; Hrusak, O.; Machova Polakova, K.

Somatic mutations in oncogenes are in chronic myeloid leukemia acquired de novo via deregulated base-excision repair and alternative non-homologous end joining

[year of publication 2021, impact factor 6.244 ]

[197]

Jaruskova, M.; Curik, N.; Hercog, R.; Polivkova, V.; Motlova, E.; Benes, V.; Klamova, H.; Pecherkova, P.; Belohlavkova, P.; Vrbacky, F.; Machova Polakova, K.

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

[year of publication 2017, impact factor 6.217 ]

[198]

Jose, S.S.; De Zuani, M.; Tidu, F.; Hortová Kohoutková, M.; Pazzagli, L.; Forte, G.; Spaccapelo, R.; Zelante, T.; Frič, J.

Comparison of two human organoid models of lung and intestinal inflammation reveals Toll-like receptor signalling activation and monocyte recruitment

[year of publication 2020, impact factor 6.161 ]

[199]

Antonarakis, S.E.; Holoubek, A.; Rapti, M.; Rademaker, J.; Meylan, J.; Iwaszkiewicz, J.; Zoete, V.; Ansar, M.; Borel, CH.; Menzel, O.; Kuzelova, K.; Santoni, F.A.

Dominant monoallelic variant in the PAK2 gene causes Knobloch syndrome type 2

[year of publication 2020, impact factor 6.150 ]

[200]

Béné, M.C.; Castoldi, G.; Derolf, A.; Garand, R.; Haas, T.; Haferlach, T.; Knapp, W.; Kuhlein, E.; Lemež, P.; Ludwig, W.D.; Marinov, I.; Matutes, E.; Michalová, K.; Porwit-MacDonald, A.; Orfao, A.; Schoch, C.; Talmant, P.; Van´t Veer, M.B.; Zemanová, Z.; Zühlsdorf, M.

Near-tetraploid acute myeloid leukemias : an EGIL retrospective study of 25 cases

[year of publication 2007, impact factor 6.146]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here